Convalescent Plasma in the Treatment of Covid-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
One hundred patients hospitalized and in need of oxygen treatment due to Covid-19 should be randomized and 50% treated with 200 ml convalescent plasma x 3 and 50% given ordinary treatment. Primary outcome is number of days the patients need oxygen within 28 days from inclusion. Secondary outcome is number of days in hospital, number of days in respirator and mortality. Side effects of treatment is monitored.
Epistemonikos ID: 86ed2be3dbbd25f3b15f5e48c3d4fc403fad2977
First added on: Oct 24, 2020